Welcoming Steven Splinter as Fractional COO
We are proud to welcome Dr. Steven Splinter as ZAPetite’s fractional COO. Dr. Splinter brings over 25 years of executive leadership in biotechnology, commercialization, and intellectual property strategy. He previously served as Chief Technology Officer at Radient Technologies, where he led the development and scaling of novel natural product extraction platforms. He is currently a Project Coordinator and IP Specialist at the Conestoga Centre for Commercialization and an Entrepreneur-in-Residence with the Lab2Market program, advising Canada’s top emerging STEM ventures. With a PhD in Engineering Science from Western University and a proven track record in translating IP into market-ready technologies, Dr. Splinter brings invaluable experience to guide ZAPetite’s transition from preclinical development to clinical and commercial success.
Updated